Methylphenidate normalizes elevated dopamine transporter densities in an animal model of the attention-deficit/hyperactivity disorder combined type, but not to the same extent in one of the attention-deficit/hyperactivity disorder inattentive type.

Department of Child and Adolescent Psychiatry, University of Goettingen, Germany.
Neuroscience (Impact Factor: 3.33). 03/2010; 167(4):1183-91. DOI: 10.1016/j.neuroscience.2010.02.073
Source: PubMed

ABSTRACT The spontaneously hypertensive rat (SHR/NCrl) is a validated model of attention-deficit/hyperactivity disorder (ADHD) combined subtype, whereas a recently identified substrain of the Wistar Kyoto rat (WKY/NCrl) is a model of ADHD inattentive subtype. In this study, we first examined the expression of genes involved in dopamine signaling and metabolism in the dorsal striatum and ventral mesencephalon of these two rat strains, as well as three reference control strains (WKY/NHsd, WK/HanTac, and SD/NTac) using quantitative real time RT-PCR. Next, striatal dopamine transporter (DAT) density was determined by ligand binding assay in the two ADHD-like strains at different developmental stages and after methylphenidate treatment. In adult rats, the mRNA expression of DAT and tyrosine hydroxylase was elevated in SHR/NCrl and WKY/NCrl rats compared to control strains, with differences between SHR/NCrl and WKY/NCrl rats also evident. During normal development, changes of striatal DAT densities occurred in both strains with lower densities in WKY/NCrl compared to SHR/NCrl after day 25. Two-weeks methylphenidate treatment during different developmental stages was associated with decreased striatal DAT density in both rat strains compared to the non-treated rats with more pronounced effects followed prepubertal treatment. These results suggest differences in the pathophysiology of the combined versus the predominantly inattentive animal model of ADHD. Finally, treatment with methylphenidate might reduce elevated DAT levels more effectively in the combined subtype especially when applied before puberty.

  • [Show abstract] [Hide abstract]
    ABSTRACT: A commonly used method of diagnosis epilepsy is an EEG or electroencephalogram, which measures the patient's electrical activity along the scalp. In clinical practice, EEG refers to the recording of the brain's spontaneous electrical activity over a determined period of time. Analysis of EEG recording mainly involve spectral content of EEG, that is, the type of neural oscillations that can be observed in EEG signals. The similarity in EEG spectral profiles between two rat strains, spontaneously hypertensive rats (SHRs) and kainate (KA)-treated normotensive rats, was suggested to involve common mechanisms in genetically determined generation of specific forms of oscillations in humans modeling temporal lobe epilepsy (TLE). In the present study, we aimed to compare cortical electroencephalogram (EEG) and clinical seizures of SHRs and Wistar rats in KA model of TLE. The power spectrums of baseline and epileptic EEGs were also investigated. We found no significant difference in the dose of KA required to induce status epilepticus (SE) between the two strains. However, the frequency of spontaneous motor seizures was higher in SHRs than in Wistar rats during the stable chronic epileptic phase. In SHRs, the baseline EEG and EEG during SE, the latent and chronic phase was characterized by dominating theta activity and increased delta activity, which was detected in Wistar rats only during SE and the chronic epileptic phase. In conclusion, our findings showed similarity in EEG spectral profiles in SHRs before and after KA-induced SE, which is in line with the detected more severe seizure activity in this strain than in Wistar rats during the stable chronic epileptic phase.© Anita Publications. All rights reserved.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Dopaminergic system of the brain is believed to be strongly involved in normal and pathological behavioral phenotypes of attention. In metacontrast masking studies attentional effects on metacontrast are predominantly expressed when time intervals between a target stimulus and a masking stimulus are longer rather than shorter. Taken together, this predicts that variability in common genes known to be involved in dopaminergic function could interact with target/mask intervals in determining the effects of metacontrast masking. We tested this by genotyping participants of the masking experiment for the COMT Val158Met, DAT1 3'UTR 40bp VNTR, and DRD4 exon 3 48bp VNTR variability. We found that Val homozygotes and subjects with long repeat variants of the DRD4 gene showed relatively higher level of correct target perception with a longer target/mask time interval than with a shorter time interval while DAT1 variability did not have any effects. Implications of this result for the development of psychophysical testing based methods of screening for vulnerability/resilience in relation to the pathology of the dopaminergic systems related attentional dysfunction are considered. Copyright © 2015. Published by Elsevier Ltd.
    Neuropsychologia 03/2015; 71:112-118. DOI:10.1016/j.neuropsychologia.2015.03.022 · 3.45 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Attention-deficit hyperactivity disorder (ADHD) is estimated to affect 8-12% of school-age children worldwide. ADHD is a complex disorder with significant genetic contributions. However, no single gene has been linked to a significant percentage of cases, suggesting that environmental factors may contribute to ADHD. Here, we used behavioral, molecular, and neurochemical techniques to characterize the effects of developmental exposure to the pyrethroid pesticide deltamethrin. We also used epidemiologic methods to determine whether there is an association between pyrethroid exposure and diagnosis of ADHD. Mice exposed to the pyrethroid pesticide deltamethrin during development exhibit several features reminiscent of ADHD, including elevated dopamine transporter (DAT) levels, hyperactivity, working memory and attention deficits, and impulsive-like behavior. Increased DAT and D1 dopamine receptor levels appear to be responsible for the behavioral deficits. Epidemiologic data reveal that children aged 6-15 with detectable levels of pyrethroid metabolites in their urine were more than twice as likely to be diagnosed with ADHD. Our epidemiologic finding, combined with the recapitulation of ADHD behavior in pesticide-treated mice, provides a mechanistic basis to suggest that developmental pyrethroid exposure is a risk factor for ADHD.-Richardson, J. R., Taylor, M. M., Shalat, S. L., Guillot III, T. S., Caudle, W. M., Hossain, M. M., Mathews, T. A., Jones, S. R., Cory-Slechta, D. A., Miller, G. W. Developmental pesticide exposure reproduces features of attention deficit hyperactivity disorder. © FASEB.